Clinical Trials Directory

Trials / Completed

CompletedNCT03956459

Evaluation of PET-CT Scanner Performances to Detect Infra-centimetric Lesions in Patients With Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Institut Claudius Regaud · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Prospective, monocentric study aiming to evaluate the PET-CT (Positron Emission Tomography - Computed Tomography) scanner performances to detect infra-centimetric lesions in two groups of patients with cancer and of different BMI (Body Mass Index) classes (BMI ≤ 25 and BMI \> 25). For each patient, two consecutive PET-CT scanner will be performed using the "Discovery MI" and "Discovery IQ" PET-CT scanner systems. Virtual lesions will then be created on images obtained. Images will be interpreted by two independent observers. The study participation of each patient will be a maximum of 24 hours.

Conditions

Interventions

TypeNameDescription
OTHERPatients with a cancer for which a FDG-PET scanner must be performedFor each patient, 2 consecutive PET-CT scanners will be performed using 2 different systems of PET-CT scanners: * "Discovery MI" * "Discovery IQ" Only one contrast agent injection (FDG) will be given for both scanners.

Timeline

Start date
2019-07-25
Primary completion
2021-02-04
Completion
2021-02-04
First posted
2019-05-20
Last updated
2026-04-14

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03956459. Inclusion in this directory is not an endorsement.